Cargando…

Oncogenic herpesvirus KSHV triggers hallmarks of alternative lengthening of telomeres

To achieve replicative immortality, cancer cells must activate telomere maintenance mechanisms to prevent telomere shortening. ~85% of cancers circumvent telomeric attrition by re-expressing telomerase, while the remaining ~15% of cancers induce alternative lengthening of telomeres (ALT), which reli...

Descripción completa

Detalles Bibliográficos
Autores principales: Lippert, Timothy P., Marzec, Paulina, Idilli, Aurora I., Sarek, Grzegorz, Vancevska, Aleksandra, Bower, Mark, Farrell, Paul J., Ojala, Päivi M., Feldhahn, Niklas, Boulton, Simon J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7820467/
https://www.ncbi.nlm.nih.gov/pubmed/33479235
http://dx.doi.org/10.1038/s41467-020-20819-4
_version_ 1783639220160561152
author Lippert, Timothy P.
Marzec, Paulina
Idilli, Aurora I.
Sarek, Grzegorz
Vancevska, Aleksandra
Bower, Mark
Farrell, Paul J.
Ojala, Päivi M.
Feldhahn, Niklas
Boulton, Simon J.
author_facet Lippert, Timothy P.
Marzec, Paulina
Idilli, Aurora I.
Sarek, Grzegorz
Vancevska, Aleksandra
Bower, Mark
Farrell, Paul J.
Ojala, Päivi M.
Feldhahn, Niklas
Boulton, Simon J.
author_sort Lippert, Timothy P.
collection PubMed
description To achieve replicative immortality, cancer cells must activate telomere maintenance mechanisms to prevent telomere shortening. ~85% of cancers circumvent telomeric attrition by re-expressing telomerase, while the remaining ~15% of cancers induce alternative lengthening of telomeres (ALT), which relies on break-induced replication (BIR) and telomere recombination. Although ALT tumours were first reported over 20 years ago, the mechanism of ALT induction remains unclear and no study to date has described a cell-based model that permits the induction of ALT. Here, we demonstrate that infection with Kaposi’s sarcoma herpesvirus (KSHV) induces sustained acquisition of ALT-like features in previously non-ALT cell lines. KSHV-infected cells acquire hallmarks of ALT activity that are also observed in KSHV-associated tumour biopsies. Down-regulating BIR impairs KSHV latency, suggesting that KSHV co-opts ALT for viral functionality. This study uncovers KSHV infection as a means to study telomere maintenance by ALT and reveals features of ALT in KSHV-associated tumours.
format Online
Article
Text
id pubmed-7820467
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-78204672021-01-29 Oncogenic herpesvirus KSHV triggers hallmarks of alternative lengthening of telomeres Lippert, Timothy P. Marzec, Paulina Idilli, Aurora I. Sarek, Grzegorz Vancevska, Aleksandra Bower, Mark Farrell, Paul J. Ojala, Päivi M. Feldhahn, Niklas Boulton, Simon J. Nat Commun Article To achieve replicative immortality, cancer cells must activate telomere maintenance mechanisms to prevent telomere shortening. ~85% of cancers circumvent telomeric attrition by re-expressing telomerase, while the remaining ~15% of cancers induce alternative lengthening of telomeres (ALT), which relies on break-induced replication (BIR) and telomere recombination. Although ALT tumours were first reported over 20 years ago, the mechanism of ALT induction remains unclear and no study to date has described a cell-based model that permits the induction of ALT. Here, we demonstrate that infection with Kaposi’s sarcoma herpesvirus (KSHV) induces sustained acquisition of ALT-like features in previously non-ALT cell lines. KSHV-infected cells acquire hallmarks of ALT activity that are also observed in KSHV-associated tumour biopsies. Down-regulating BIR impairs KSHV latency, suggesting that KSHV co-opts ALT for viral functionality. This study uncovers KSHV infection as a means to study telomere maintenance by ALT and reveals features of ALT in KSHV-associated tumours. Nature Publishing Group UK 2021-01-21 /pmc/articles/PMC7820467/ /pubmed/33479235 http://dx.doi.org/10.1038/s41467-020-20819-4 Text en © The Author(s) 2021 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Lippert, Timothy P.
Marzec, Paulina
Idilli, Aurora I.
Sarek, Grzegorz
Vancevska, Aleksandra
Bower, Mark
Farrell, Paul J.
Ojala, Päivi M.
Feldhahn, Niklas
Boulton, Simon J.
Oncogenic herpesvirus KSHV triggers hallmarks of alternative lengthening of telomeres
title Oncogenic herpesvirus KSHV triggers hallmarks of alternative lengthening of telomeres
title_full Oncogenic herpesvirus KSHV triggers hallmarks of alternative lengthening of telomeres
title_fullStr Oncogenic herpesvirus KSHV triggers hallmarks of alternative lengthening of telomeres
title_full_unstemmed Oncogenic herpesvirus KSHV triggers hallmarks of alternative lengthening of telomeres
title_short Oncogenic herpesvirus KSHV triggers hallmarks of alternative lengthening of telomeres
title_sort oncogenic herpesvirus kshv triggers hallmarks of alternative lengthening of telomeres
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7820467/
https://www.ncbi.nlm.nih.gov/pubmed/33479235
http://dx.doi.org/10.1038/s41467-020-20819-4
work_keys_str_mv AT lipperttimothyp oncogenicherpesviruskshvtriggershallmarksofalternativelengtheningoftelomeres
AT marzecpaulina oncogenicherpesviruskshvtriggershallmarksofalternativelengtheningoftelomeres
AT idilliaurorai oncogenicherpesviruskshvtriggershallmarksofalternativelengtheningoftelomeres
AT sarekgrzegorz oncogenicherpesviruskshvtriggershallmarksofalternativelengtheningoftelomeres
AT vancevskaaleksandra oncogenicherpesviruskshvtriggershallmarksofalternativelengtheningoftelomeres
AT bowermark oncogenicherpesviruskshvtriggershallmarksofalternativelengtheningoftelomeres
AT farrellpaulj oncogenicherpesviruskshvtriggershallmarksofalternativelengtheningoftelomeres
AT ojalapaivim oncogenicherpesviruskshvtriggershallmarksofalternativelengtheningoftelomeres
AT feldhahnniklas oncogenicherpesviruskshvtriggershallmarksofalternativelengtheningoftelomeres
AT boultonsimonj oncogenicherpesviruskshvtriggershallmarksofalternativelengtheningoftelomeres